CytomX Therapeutics, Inc. - COM (CTMX)

Historical Portfolio Holders from Q4 2015 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
50.7M
Holdings value Q2 2024
$61.9M
Value change Q2 2024
+$882K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
73
Number of buys Q2 2024
41
Number of sells Q2 2024
-49
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 50.7M $61.9M +$882K $1.22 73
2024 Q1 44.3M $96.6M +$25.5M $2.18 84
2023 Q4 32.6M $50.6M +$410K $1.55 66
2023 Q3 32.4M $41.8M -$2.42M $1.29 61
2023 Q2 34.1M $58.7M -$2.38M $1.72 66
2023 Q1 35.6M $53.8M -$933K $1.51 74
2022 Q4 36M $120M -$725K $1.60 77
2022 Q3 36.3M $52.6M -$19M $1.45 76
2022 Q2 45.6M $83.4M -$17.8M $1.83 86
2022 Q1 53.7M $143M -$1.75M $2.67 112
2021 Q4 54.3M $235M -$5.31M $4.33 106
2021 Q3 54M $275M -$17.3M $5.09 112
2021 Q2 56.7M $359M +$4.31M $6.33 119
2021 Q1 54.6M $422M +$130M $7.73 123
2020 Q4 38M $249M +$5.58M $6.55 123
2020 Q3 36.8M $245M -$11.6M $6.65 128
2020 Q2 37.8M $315M +$15.5M $8.33 133
2020 Q1 36.1M $277M +$245K $7.67 113
2019 Q4 36M $299M -$9.33M $8.31 119
2019 Q3 35.8M $264M -$1.38M $7.38 111
2019 Q2 35.6M $400M -$8.09M $11.22 108
2019 Q1 36.9M $397M -$12.8M $10.75 110
2018 Q4 37.8M $570M -$2.75M $15.10 109
2018 Q3 37.8M $697M +$95.6M $18.50 120
2018 Q2 32.3M $739M +$66.1M $22.86 140
2018 Q1 28.6M $814M +$73.3M $28.45 135
2017 Q4 30.1M $637M +$56M $21.11 119
2017 Q3 24.2M $441M +$41.7M $18.17 97
2017 Q2 22.1M $343M +$45M $15.50 88
2017 Q1 19.2M $331M +$57.9M $17.27 86
2016 Q4 16.9M $185M +$15M $10.99 68
2016 Q3 15.5M $243M +$18M $15.68 61
2016 Q2 18.8M $192M +$9.42M $10.21 59
2016 Q1 17.7M $228M +$3.39M $12.90 49
2015 Q4 12.5M $258M +$240M $20.87 46